Cited by 287Cancer, Lipids, and MetabolismLipid metabolism and biosynthesisLipid metabolism and disorders

The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.

Lipoprotein Lipase Links Dietary Fat to Solid Tumor Cell Proliferation

Open access

Kuemmerle, Nancy B., Rysman, Evelien, Lombardo, Portia S., Flanagan, Alison J., Lipe, Brea C., Wells, Wendy A., Pettus, Jason R., Froehlich, Heather M., Memoli, Vincent A., Morganelli, Peter M., Swinnen, Johannes V., Timmerman, Luika A., Chaychi, Leila, Fricano, Catherine J., Eisenberg, Burton L., Coleman, William B., Kinlaw, William B.·2011·Molecular Cancer Therapeutics

DOI 10.1158/1535-7163.mct-10-0802PMC PMC3074101

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

Many types of cancer cells require a supply of fatty acids (FA) for growth and survival, and interrupting de novo FA synthesis in model systems causes potent anticancer effects. We hypothesized that, in addition to synthesis, cancer cells may obtain preformed, diet-derived FA by uptake from the bloodstream. This would require hydrolytic release of FA from triglyceride in circulating lipoprotein particles by the secreted enzyme lipoprotein lipase (LPL), and the expression of CD36, the channel for cellular FA uptake. We find that selected breast cancer and sarcoma cells express and secrete active LPL, and all express CD36. We further show that LPL, in the presence of triglyceride-rich lipoproteins, accelerates the growth of these cells. Providing LPL to prostate cancer cells, which express low levels of the enzyme, did not augment growth, but did prevent the cytotoxic effect of FA synthesis inhibition. Moreover, LPL knockdown inhibited HeLa cell growth. In contrast to the cell lines, immunohistochemical analysis confirmed the presence of LPL and CD36 in the majority of breast, liposarcoma, and prostate tumor tissues examined (n = 181). These findings suggest that, in addition to de novo lipogenesis, cancer cells can use LPL and CD36 to acquire FA from the circulation by lipolysis, and this can fuel their growth. Interfering with dietary fat intake, lipolysis, and/or FA uptake will be necessary to target the requirement of cancer cells for FA.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1158/1535-7163.mct-10-0802

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
Sørlie, T., Perou, C. M., Tibshirani, R. J., Aas, T., Geisler, S. B., Johnsen, H., Hastie, T. J., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 11,506
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppé, J., Tong, F. K., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,224
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
[19] Receptor-mediated endocytosis of low-density lipoprotein in cultured cells
Goldstein, J. L., Basu, S. K., & Brown, M. S. (1983) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(83)98152-1 · Cited by 1,629
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S., Puigserver, P., & Brugge, J. S. (2009) · Nature · doi:10.1038/nature08268 · Cited by 1,031
Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis
Nomura, D. K., Long, J. Z., Niessen, S., Hoover, H. S., Ng, S.-W., & Cravatt, B. F. (2010) · Cell · doi:10.1016/j.cell.2009.11.027 · Cited by 1,002

Show all 46 references

Research works printed but not linked: 2

Weiss, 1986, Fatty-acid biosynthesis in man, a pathway of minor importance, J Biol Chem, 367, 905
Parlo, 1984, Enhanced rate of citrate export from cholesterol-rich hepatoma mitochondria, J Biol Chem, 259.

Sorted by citations

Items 201–287 of 287

Role of Adipose Cells in Tumor Microenvironment
Zhang, T., & Kolonin, M. G. (2013) · Studies in mechanobiology, tissue engineering and biomaterials · doi:10.1007/8415_2013_171 · Cited by 7
Translational Research on the Oral Delivery of the Cytotoxic PROTAC Molecule via Tumor-Targeting Prodrug Strategy for Triple-Negative Breast Cancer Treatment
Hu, H., Wang, Y., Wang, M., Zhang, Z., Gu, X., Sun, R., Liu, X., Li, N., Ding, N., Li, W., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01640 · Cited by 6
Metabolomics as a tool for understanding and treating triple-negative breast cancer
Khan, G., Hussain, M. S., Ahmad, S., Alam, N., Ali, S., & Alam, P. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04234-4 · Cited by 6
Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer
Kwan, K. H., Burvenich, I. J. G., Centenera, M. M., Goh, Y. W., Rigopoulos, A., Dehairs, J., Swinnen, J. V., Raj, G. V., Hoy, A. J., Butler, L. M., et al. (2020) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2020.11.007 · Cited by 6
β-Estradiol Enhanced Secretion of Lipoprotein Lipase from Mouse Mammary Tumor FM3A Cells
Fujii, T., Ogasawara, M., Kamishikiryo, J., & Morita, T. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00408 · Cited by 6
Histone methyltransferase KMT2D mediated lipid metabolism via peroxisome proliferator-activated receptor gamma in prostate cancer
Zhai, Q., Luo, M., Zhang, Y., Zhang, W., Wu, C., Lv, S., & Wei, Q. (2022) · Translational Cancer Research · doi:10.21037/tcr-22-431 · Cited by 6
Acidosis Forces Fatty Acid Uptake and Metabolism in Cancer Cells Regardless of Genotype
Ibanez, S., Giolito, M. V., Al‐Siyabi, S., Serafimov, K., Laloux-Morris, F., Dierge, E., Aubert, L., Guilbaud, C., Kaye, S., Rugeles, P. V., et al. (2025) · Advanced Science · doi:10.1002/advs.202505436 · Cited by 5
A Proof-of-Concept Inhibitor of Endothelial Lipase Suppresses Triple-Negative Breast Cancer Cells by Hijacking the Mitochondrial Function
Yang, R., Han, S., Clayton, J., Haghighatian, M., Tsai, C.-C., Yao, Y., Li, P., Shen, J., & Zhou, Q. Y. (2022) · Cancers · doi:10.3390/cancers14153763 · Cited by 6
Assessing CD36 and CD47 expression levels in solid tumor indications to stratify patients for VT1021 treatment
Wang, S., Zota, V. E., Vincent, M. Y., Clossey, D., Chen, J., Cieslewicz, M., Watnick, R. S., Mahoney, J., & Watnick, J. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00774-9 · Cited by 5
Atypical plasma lipid profiles in leukemia
Iqbal, A., Zaid, M., Munir, R., Usman, H., Kalbacher, H., Scandiuzzi, L., & Zaidi, N. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.11.003 · Cited by 5
Integrated mRNA‐Seq and miRNA‐Seq analysis of PLCγ2‐overexpressing hepatocarcinoma cells and identification of the associated miRNA‐mRNA network
Chen, X., Zhu, X., Wei, Z., & Lv, Q. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29294 · Cited by 5
Catabolic rewiring in cancer impacts dietary interventions
Chinopoulos, C. (2025) · Communications Biology · doi:10.1038/s42003-025-09333-9 · Cited by 6
Association of D4-GDI expression with breast cancer progression
Rosado, L. A. R., Rodriguez‐Canales, J., & Zhang, B. (2012) · Cancer Biomarkers · doi:10.3233/cbm-2012-0240 · Cited by 4
Inaugurating a novel adjuvant therapy in urological cancers: Ferroptosis
Xie, Z., Zhou, Q., Qiu, C., Zhu, D., Li, K., & Huang, H. W. (2022) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2022.10.002 · Cited by 6
Unravelling the role of obesity and lipids during tumor progression
Zhao, J., Lee, K., Toh, H. C., Lam, K., & Neo, S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1163160 · Cited by 5
Correlated metabolomic, genomic, and histologic phenotypes in histologically normal breast tissue
Sun, X., Stewart, D. A., Sandhu, R., Kirk, E. L., Pathmasiri, W., McRitchie, S., Clark, R. F., Troester, M. A., & Sumner, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193792 · Cited by 4
Knowledge Integration and Representation for Biomedical Analysis
Alachram, H. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8464 · Cited by 4
Grade 4 very severe hypertriglyceridaemia at diagnosis in a child with acute lymphoblastic leukaemia
Khera, S., Kapoor, R., Sunder, S., & Mahajan, D. (2022) · BMJ Case Reports · doi:10.1136/bcr-2021-245820 · Cited by 3
Clinical significance of lipid pathway-targeted therapy in breast cancer
Li, D., Jin, P., Cai, Y., Wu, S., Guo, X., Zhang, Z., Liu, K., Li, P., Hu, Y., & Zhou, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1514811 · Cited by 4
Carcinoma espinocelular oral
MOREIRA, F. D. S. (2017) · doi:10.47749/t/unicamp.2017.989712 · Cited by 3
Lipid metabolism-associated immune gene LPL promotes M1 macrophage polarization and inhibits breast cancer progression
Yang, L., Fang, X., Liu, X., Liu, Y., & Zhao, S. (2025) · Tissue and Cell · doi:10.1016/j.tice.2025.103071 · Cited by 2
Future perspective of clinical usefulness of metabolic and mitochondrial heterogeneity in triple-negative breast cancers
Li, J., Velaga, R., Takano, Y., & Masuda, N. (2025) · International Journal of Clinical Oncology · doi:10.1007/s10147-025-02916-w · Cited by 2
Nutritional modulation of metabolic signaling within the tumor microenvironment for cancer therapy
Aghdam, M. M., Rezagholizadeh, L., Fazaeli, A., Moradi, A., & Ojarudi, M. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05462-1 · Cited by 3
Regulation of Lipid Metabolism Under Stress and Its Role in Cancer
Munir, R., & Zaidi, N. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-07634-3_3 · Cited by 3
Cancer Cell Metabolism Featuring Nrf2
Chatterjee, P., Yadav, M., Chauhan, N., Huang, Y. S., & Luo, Y. (2018) · Current Drug Discovery Technologies · doi:10.2174/1570163815666180911092443 · Cited by 2
Metabolic reprogramming and immunity in cancer
Chen, Y., & Li, Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823397-9.00006-5 · Cited by 2
Lipotoxicity as a Barrier for T Cell-Based Therapies
Loschinski, R., Saborido, J. R., Böttcher, M., Kahlfuß, S., & Mougiakakos, D. (2022) · Biomolecules · doi:10.3390/biom12091182 · Cited by 2
Triptolide Reduces Neoplastic Progression in Hepatocellular Carcinoma by Downregulating the Lipid Lipase Signaling Pathway
Chang, W., Wang, J., You, Y., Wang, H., Xu, S., Vulcano, S., Xu, C., Shen, C., Li, Z., & Wang, J. (2024) · Cancers · doi:10.3390/cancers16030550 · Cited by 1
ATR-FTIR spectroscopic analysis of lipids and partial least squares analysis: the early detection of breast cancers
Walpita, P., Manage, S. A., Gunawardana, D. N., Gunasekara, B., Keerthi, A. A. P., Haputhanthri, P. R., & Perera, M. (2025) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2025.127036 · Cited by 1
The Role of CD36 and Its Regulatory Mechanisms in Metabolic Dysregulation and Tumorigenesis
Tong, C., Feng, W., Yu, H., Liu, Q., Liang, Y., Lan, D., Liu, Q., & Song, B. (2025) · Scandinavian Journal of Immunology · doi:10.1111/sji.70065 · Cited by 2
ANGPTL3, Apo CIII, Leptin and Triglycerides Are Elevated in Metastatic Prostate Cancer
Boulay, G., Khodr, M., Bergeron, A.-C., Chong, E. W., Joncas, F., Castonguay, C., Robitaille, K., Hovington, H., Fradet, V., Bergeron, A., et al. (2026) · Cancers · doi:10.3390/cancers18071176 · Cited by 1
Lipid biomarkers of prostate cancer: insights from triglycerides and saturated fatty acid metabolism
Jx, H., & Li, P. Z. (2026) · Future Oncology · doi:10.1080/14796694.2026.2707002 · Cited by 1
Biomarker
Khan, T. K. (2012) · InTech eBooks · doi:10.5772/2376 · Cited by 1
Fatty acid metabolism related gene MECR contributes to the progression of prostate cancer
Liu, Y., Wan, L., Chen, Y., Zhang, R., Yi, X., Chen, M., Huang, X., & Liu, R. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03738-6 · Cited by 1
Use of X-ray Diffraction Technique of Hair for Oral Cancer Detection: A Proposal
Maniyar, N., & Roopa, N. M. (2019) · The Journal of Contemporary Dental Practice · doi:10.5005/jp-journals-10024-2509 · Cited by 1
EMAP II Expression Is Increased on Peripheral Blood Cells from Non-Hodgkin Lymphoma
Saber, M. M. (2022) · Journal of Immunology Research · doi:10.1155/2022/7219207 · Cited by 1
Cell Surface Lipoprotein Lipase Enzyme as A Prognostic Indicator in B-Cell Chronic Lymphocytic Leukemia
Yelton, C. J., Yelton, C. J., Kuhn, E. P., Kinlaw, W. B., & Lansigan, F. (2023) · Annals of Clinical Oncology · doi:10.31487/j.aco.2023.01.02 · Cited by 1
Fatty Acid Metabolism as a Potential Therapeutic Target in Thyroid CarcinomaPreprint
Lu, J., Zhang, Y., Sun, M., Ding, C., Zhang, L., Kong, Y., Meng, C. A. I., Miccoli, P., Ma, C., & Yue, X. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3861577 · Cited by 1
A knowledge base for generating patient-specific pathways for individualized treatment decisions in clinical applications
Auer, F. (2022) · doi:10.53846/goediss-9457 · Cited by 1
Lipidomics in Breast Cancer
Kamili, A., & Byrne, J. A. (2014) · Springer eBooks · doi:10.1007/978-81-322-0843-3_11
Adipose and muscle tissue metabolism in cancer cachexia
Agustsson, T. (2011) · Figshare
Estudo dos efeitos da terapia combinada orlistat / cisplatina / 5-fluorouracil / paclitaxel em linhagem metastática de carcinoma espinocelular de língua
MOREIRA, F. D. S. (2014) · doi:10.47749/t/unicamp.2014.927942
Análise do efeito inibidor de FASN orlistat sobre a produção de IL-10, IL-12, IFN-G e TGF-B em células de melanoma murino B16-F10
Melo, E. A. (2015) · doi:10.47749/t/unicamp.2015.955354
Investigating Dysregulated Metabolic Pathways that Drive Cancer Pathogenicity
Roberts, L. S. (2017) · eScholarship (California Digital Library)
Metabolic Dysregulation in Environmental Carcinogenesis and Toxicology
Robey, R. B. (2017) · John Wiley & Sons, Inc. eBooks · doi:10.1002/9781119023647.ch15
Mapping Dysregulated Metabolic Pathways in Cancer Using Chemoproteomic and Metabolomic Platforms
Louie, S. M. (2017) · eScholarship (California Digital Library)
CYP2B6 polymorphism and lipoprotein lipase expression in chronic lymphocytic leukemia: impact on the outcome of fludarabine–cyclophosphamide regimen
Bedewy, A. L., & El-Bendary, W. (2019) · The Egyptian Journal of Haematology · doi:10.4103/ejh.ejh_32_18
Investigation of metabolic rewiring in prostate cancer cells during the adaptive response to androgen-targeted therapies
Tousignant, K. D. (2020) · Queensland University of Technology · doi:10.5204/thesis.eprints.180822
STUDY ON ROLE OF ALP, LDH AND LIPASE AS PROGNOSTIC MARKERS IN FEMALE BREAST CANCER PATIENTS OF SAURASTRA REGION OF GUJARAT
Mehta, P., Rupala, N., Rawat, S., & Goswami, G. K. (2021) · Indian Journal Of Applied Research · doi:10.36106/ijar/5013991
The Effect of Medroxyprogesterone Acetate on the Secretion of Lipoprotein Lipase in Mouse Mammary Tumor Cells
Fujii, T., Kamishikiryo, J., & Morita, T. (2021) · BPB Reports · doi:10.1248/bpbreports.4.4_130
Assinatura bioenergética como marcador de progressão e prognóstico do câncer de próstata
da Silva, R. C. (2018) · doi:10.47749/t/unicamp.2018.1045546
Explaining decisions of graph convolutional neural networks for analyses of molecular subnetworks in cancer
Chereda, H. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9215
The Discovery of Cancer Tissue Specific Proteins in Serum: Case Studies on Prostate Cancer
Spiros, D., & Paul, A. (2012) · InTech eBooks · doi:10.5772/36944
Exploring the Mechanism of Astragalus membranaceus in the Treatment of Prostate Cancer Based on Network Pharmacology and Molecular Docking
程, 晓. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.1291255
The role of fatty acids metabolism on cancer progression and therapeutics development
Moreira-Barbosa, C., Matos, A., Fernandes, R., Mendes-Ferreira, M., Rodrigues, R. C., Cruz, T., Costa, Â. M., Cardoso, A. P., Ghilardi, C., Oliveira, M. J., et al. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824043-4.00007-5
Seeking an Important Role on Metabolomics—Effects of β-Estradiol on Lipoprotein Metabolism in Mammary Tumors
Morita, T. (2022) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.22-00098
Rewiring of Drug Metabolism and Its Cross‐talk with Metabolic Reprogramming in Cancer
Majumder, S., & Manna, S. K. (2022) · Wiley eBooks · doi:10.1002/9781119851042.ch27
Cancer and Lipid Metabolism: Roles of Adipocytes on Tumor Microenvironment
Chu, D., Nguyen, Q. H., Le, B. N., Ngoc, S. M. V., Quyen, M. L., & Cao, B. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_106-1
Data from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
Larkin, J. R., Anthony, S. B., Johanssen, V. A., Yeo, T., Sealey, M. A., Yates, A. G., Smith, C. F., Claridge, T. D. W., Nicholson, B. D., Moreland, J., et al. (2023) · doi:10.1158/1078-0432.c.6531243.v1
Efeitos do paclitaxel, cisplatina e inibidores da enzima ácido graxo sintase na expressão de marcadores associados às celulas-tronco do câncer e isolamento de subpopulações em linhagens celulares de carcinoma de células escamosas oral
Zelaya, F. J. M. C. (2019) · doi:10.47749/t/unicamp.2019.1166901
Constructing a novel prognostic model of gastric cancer related to mitochondrial membrane permeability change-driven necrosis based on single cell and bulk transcriptomePreprint
Gan, X., Cheng, H., Ma, N., Wang, Z., & Mao, Z. (2024) · Research Square · doi:10.21203/rs.3.rs-4929734/v1
Interplay of nutrient stress and lipid dynamics in colorectal cancer cells
Kousar, S., Gull, S., Aqeel, M. B., Shah, F. I., Mahjabeen, I., Shahid, A., Shoaib, N., & Khan, Z. (2025) · Clinical Nutrition Open Science · doi:10.1016/j.nutos.2025.01.005
Deletions of LPL and NKX3.1 in Prostate Cancer Progression: Game Changers or By-Standers in Tumor Evolution
Vodičková, T., Wozniaková, M., Židlík, V., Žmolíková, J., Dvořáčková, J., Kondé, A., Schwarzerová, J., Grepl, M., & Bouchal, J. (2025) · Biomolecules · doi:10.3390/biom15060758
Altered lipid metabolism and adipocyte activity support HER2+ breast cancer progression
Wong, J. (2017) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/dvgm-nzy9
Detection of Breast Cancers Using Attenuated Total Reflection Fourier Transform Infrared Spectroscopy Combined with Multivariate AnalysisPreprint
Walpita, P., Manage, S. A., Gunawardana, D. N., Gunasekara, B., Punya, K. A. A., Haputhanthri, P. R., & Perera, M. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5352447
DFT studies and molecular docking approach for investigation of optoelectronic and biological properties of Pyrimethamine and Leflunomide
Amini, H., Aliabad, H. A. R., Mollania, N., Azadparvar, M., Mollania, F., & Saeed, M. A. (2025) · Optical and Quantum Electronics · doi:10.1007/s11082-025-08389-5
Combined Effects of Atorvastatin and Glucose Deprivation on Metabolic Stress and Lipid-Raft Disruption in Glioblastoma and Breast Cancer Cells
Alshaer, W., Ijjeh, Y., Alsarayreh, N., Alqudah, D. A., Rifai, A., Abu-Siniyeh, A. A., & Alsalem, M. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17101275
Cancer and Lipid Metabolism: Roles of Adipocytes on Tumor Microenvironment
Chu, D., Nguyen, Q. H., Le, B. N., Ngoc, S. M. V., Quyen, M. L., & Cao, B. A. (2025) · Springer eBooks · doi:10.1007/978-3-032-00761-2_106
Additional file 3 of EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression
Wang, Z., Chao, Z., Wang, Q., Zou, F., Song, T., Xu, L., Ning, J., & Cheng, F. (2024) · Figshare · doi:10.6084/m9.figshare.26673225
Additional file 1 of Lipoprotein lipase hydrolysis products induce pro-inflammatory cytokine expression in triple-negative breast cancer cells
Tobin, A. J., Noel, N. P., Christian, S. L., & Brown, R. (2021) · Figshare · doi:10.6084/m9.figshare.15184794
Additional file 2 of Lipoprotein lipase hydrolysis products induce pro-inflammatory cytokine expression in triple-negative breast cancer cells
Tobin, A. J., Noel, N. P., Christian, S. L., & Brown, R. (2021) · Figshare · doi:10.6084/m9.figshare.15184800
Additional file 5 of EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression
Wang, Z., Chao, Z., Wang, Q., Zou, F., Song, T., Xu, L., Ning, J., & Cheng, F. (2024) · Figshare · doi:10.6084/m9.figshare.26673231
Additional file 4 of EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression
Wang, Z., Chao, Z., Wang, Q., Zou, F., Song, T., Xu, L., Ning, J., & Cheng, F. (2024) · Figshare · doi:10.6084/m9.figshare.26673228
Additional file 1 of Explaining decisions of graph convolutional neural networks: patient-specific molecular subnetworks responsible for metastasis prediction in breast cancer
Chereda, H., Bleckmann, A., Menck, K., Perera-Bel, J., Stegmaier, P., Auer, F., Krämer, F., Leha, A., & Beißbarth, T. (2021) · Figshare · doi:10.6084/m9.figshare.14205239
Additional file 1 of EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression
Wang, Z., Chao, Z., Wang, Q., Zou, F., Song, T., Xu, L., Ning, J., & Cheng, F. (2024) · Figshare · doi:10.6084/m9.figshare.26673219
Additional file 3 of Lipoprotein lipase hydrolysis products induce pro-inflammatory cytokine expression in triple-negative breast cancer cells
Tobin, A. J., Noel, N. P., Christian, S. L., & Brown, R. (2021) · Figshare · doi:10.6084/m9.figshare.15184803
Additional file 6 of EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression
Wang, Z., Chao, Z., Wang, Q., Zou, F., Song, T., Xu, L., Ning, J., & Cheng, F. (2024) · Figshare · doi:10.6084/m9.figshare.26673234
Additional file 4 of Lipoprotein lipase hydrolysis products induce pro-inflammatory cytokine expression in triple-negative breast cancer cells
Tobin, A. J., Noel, N. P., Christian, S. L., & Brown, R. (2021) · Figshare · doi:10.6084/m9.figshare.15184806
Additional file 2 of EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression
Wang, Z., Chao, Z., Wang, Q., Zou, F., Song, T., Xu, L., Ning, J., & Cheng, F. (2024) · Figshare · doi:10.6084/m9.figshare.26673222
Development of NMR methodology for the analysis and simplification of complex mixtures
Chandran, J. N. (2013) · doi:10.70675/217d042cz6ac9z4768zb8a5z42ae01347bc1
PGC-1α régule un programme onco-métabolique capable de réprimer l’agressivité du cancer de la prostate
Kaminski, L. (2018) · theses.fr (ABES) · doi:10.70675/7f6ae88bz4f3cz49d3zafcdz8682254b2be3
Cancer de la prostate et mécanismes de résistance à la castration : étude du rôle des récepteurs nucléaires LXR
Bousset, L. (2019) · theses.fr (ABES) · doi:10.70675/45b0b676z18daz47a9zbb03zee607f300175
Targeting the metabolic environment to modulate T cell effector function
Matias, M. I. (2019) · theses.fr (ABES) · doi:10.70675/0582ddaaze61dz4707z9cb1zdb8fe1d82653
Co-conditioning and parallel cell homing-driven pre-metastatic niche engineering: TGF-β-fuelled 3D microphysiological model for epithelial-mesenchymal transition in breast cancer
Vaishnavi, M., Kumari, M., Pal, S., Kaur, K., Kaity, S., Mandal, C., & Roy, S. (2026) · In vitro models · doi:10.1007/s44164-026-00119-9
Cachexia-induced alterations of miR-27a-3p drive cell-type specific effects in FAPs and tumor cells that coincide with muscle wasting
Narasimhan, A., Cheung, C. W., Kajabadi, N., Lin, B., Tung, L. W., Chang, C., & Rossi, F. M. V. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117362 · Cited by 1
Targeting lipoprotein lipase-positive macrophage-driven GDF-15 expression alleviates cancer Cachexia in obese head and neck squamous cell carcinoma
Guo, Y.-J., Zhao, R., Li, Y. Q., Cui, J.-J., Zhao, M.-R., Yang, Y., Wu, J.-Y., Zhao, J.-H., & Song, X. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112722
Targeting the CAF–LPL–STAT3 axis mitigates osimertinib resistance associated with EGFR downregulation
Ye, F., Wu, J., Liu, D., 李俞慧, Zhu, N., & Chen, L. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112911

Authors: Kuemmerle, N. B., Rysman, E., Lombardo, P. S., Flanagan, A. J., Lipe, B. C., Wells, W. A., Pettus, J. R., Froehlich, H. M., Memoli, V. A., Morganelli, P. M., Swinnen, J. V., Timmerman, L. A., Chaychi, L., Fricano, C. J., Eisenberg, B. L., Coleman, W. B., & Kinlaw, W. B.
Affiliations: Dartmouth–Hitchcock Medical Center (US)
University of North Carolina at Chapel Hill (US)
Corresponding author: Kinlaw, William B.
ORCID: Lombardo, Portia S.
Lipe, Brea C.
Wells, Wendy A.
Pettus, Jason R.
Swinnen, Johannes V.
Coleman, William B.
Kinlaw, William B.
Venue: Molecular Cancer Therapeutics
Publisher: American Association for Cancer Research (AACR)
Published: 2011-03-01
Volume: 10
Issue: 3
Pages: 427-436
ISSN: 1535-7163 (ISSN-L)
1538-8514
DOI: 10.1158/1535-7163.mct-10-0802
PMC: PMC3074101
OpenAlex: W2117594441
Cited by: 286
References: 46
Citations by year: 2026: 7 · 2025: 18 · 2024: 22 · 2023: 20 · 2022: 31 · 2021: 35 · 2020: 24 · 2019: 32 · 2018: 19 · 2017: 16 · 2016: 21 · 2015: 11 · 2014: 9 · 2013: 8 · 2012: 11
FWCI: 3.26
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Molecular Cancer Therapeutics (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
UNC Libraries
Funders: Howard Hughes Medical Institute (52005870)
Dartmouth College
Fonds Wetenschappelijk Onderzoek
Universität Ulm
Vlaamse regering
Norris Cotton Cancer Center
National Cancer Institute (R01CA126618, P50CA058207, P30CA023108)
National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007508, DK 07508)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords: lipoprotein lipase, CD36, fatty acid uptake, dietary fat, solid tumor growth, lipolysis, triglyceride-rich lipoproteins, breast cancer, sarcoma, prostate cancer, fatty acid synthesis inhibition, cancer metabolism
MeSH terms: Animals, Dietary Fats, Fatty Acids, Female, Humans, Lipolysis, Lipoprotein Lipase, Liposarcoma, Male, Mice, Transgenic, Neoplasms, CD36 Antigens, Oligonucleotide Array Sequence Analysis, RNA, Small Interfering, Cell Line, Tumor, Cell Proliferation, Mice, Fatty Acid Synthesis Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Lipoprotein Lipase Links Dietary Fat to Solid Tumor Cell Proliferation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks